Premium
Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma
Author(s) -
Fukai Kenichi,
Yokosuka Osamu,
Imazeki Fumio,
Tada Motohisa,
Mikata Rintaro,
Miyazaki Masaru,
Ochiai Takenori,
Saisho Hiromitsu
Publication year - 2005
Publication title -
liver international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.873
H-Index - 110
eISSN - 1478-3231
pISSN - 1478-3223
DOI - 10.1111/j.1478-3231.2005.01162.x
Subject(s) - p14arf , methylation , hepatocellular carcinoma , dna methylation , biology , epigenetics , cancer research , promoter , gene , locus (genetics) , microbiology and biotechnology , gene expression , tumor suppressor gene , carcinogenesis , genetics
Background: The INK4 locus consisting of three genes involved in the regulation of cell cycle, p16INK4a , p15INK4b , and p14ARF is often disrupted in human neoplasms. Methods: We analyzed the promoter methylation of each gene by methylation‐specific PCR in hepatocellular carcinoma (HCC). Results: The methylation of p16INK4a , p15INK4b , and p14ARF was found to occur in 27 (69.2%), seven (17.9%), and none out of 39 HCC tumors, respectively. Regarding corresponding nontumorous liver tissues, the promoter regions of p16INK4a , p15INK4b , and p14ARF were methylated in three (17.6%), three (17.6%), and none out of 17 samples, respectively. Analysis of mRNA expression revealed that loss of p16INK4a expression was frequently observed in HCC. In contrast, transcripts of p14ARF and p15INK4b were detected in 16 (88.9%) and 16 (88.9%) of 18 tumors, respectively. Conclusions: The frequent loss of transcription of p16INK4a with promoter methylation not only in the advanced but also in the early stages of HCC suggests that the epigenetic alteration of p16INK4a promoter is likely to be involved in hepatocarcinogenesis. Together with the result of RT‐PCR analysis, the role of aberrant methylation of p14ARF or p15INK4a promoter in hepatocarcinogenesis is thought to be limited.